Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Bone Biologics (BBLG) Equity Ratio (2016 - 2017)

Bone Biologics (BBLG) has disclosed Equity Ratio for 2 consecutive years, with 6.1 as the latest value for Q3 2017.

  • On a quarterly basis, Equity Ratio rose 32.39% to 6.1 in Q3 2017 year-over-year; TTM through Sep 2017 was 6.1, a 32.39% increase, with the full-year FY2016 number at 11.93, changed N/A from a year prior.
  • Equity Ratio was 6.1 for Q3 2017 at Bone Biologics, up from 11.14 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.75 in Q1 2016 to a low of 11.93 in Q4 2016.